Clinical trial
Effect of Nasal Highflow in Combination With a Nebulizer on Reversibility in Lung Function in Patients With COPD
NCT02885103 is registered in ClinicalTrials.gov with University of Leipzig as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Nasal Highflow in Combination With a Nebulizer on Reversibility in Lung Function in Patients With COPD
- Lead sponsor
- University of Leipzig
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 31, 2016
- Completion date
- November 30, 2017
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic obstructive pulmonary disease